Within days of its $60 million settlement of a long-running legal dispute over the iPad trademark with Chinese struggling monitor firm Proview, Apple has now announced that its new iPad will hit the China stores on July 20.
In a Tuesday statement pertaining to the Chinese availability of the new iPad, Apple said that the company's popular tablet - which was launched in the US in March - will be priced at a range of between $499 and $829, depending on the storage capacity of the device as well as its wireless-connection compatibility.
According to Apple's announcement, the new iPad will become available for purchase in China by booking only at Apple retail stores. The tablet will also be available for sale at the country's authorized resellers as well as the Apple online store.
The forthcoming launch of the new iPad in China marks Apple's efforts in the direction of extending its lead in the growing tablet market by opening up a new business opportunity in the most populous country of the world.
The availability of the new iPad in China will also be a notable move for Apple, especially in the wake of the fact that the country has already become Apple's second-biggest market after the US; with increasing wages giving the Chinese more disposable income for spending on the company's popular devices, chiefly including its iPhones, iPads and Mac computers.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).